28 active shortage notices across 6 countries · 9 anticipated.
Last updated 2 Aug 2026 · sourced from official medicines regulators
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| Australia | critical | 11 | 30 Apr 2024 | 31 Mar 2027 | TGA |
| European Union | high | 1 | 29 Jun 2026 | — | EMA |
| Canada | medium | 8 | 2 May 2018 | 25 Jul 2026 | HC |
| Belgium | medium | 4 | 22 Oct 2025 | 15 Sept 2026 | FAMHP |
| United States | medium | 2 | 24 Apr 2025 | — | FDA |
| Malaysia | medium | 2 | 1 Jan 2020 | — | NPRA |
Clinically related options from Mederti's curated alternatives data. Always confirm suitability with a pharmacist or prescriber before substituting.
Yes. As of the latest regulator updates, Topiramate has 28 active shortage notices across 6 countries (Australia, European Union, Canada, Belgium, United States, Malaysia). Status is refreshed daily from official regulatory sources.
Regulators attribute the current Topiramate shortages to manufacturing problems, causes not stated by the regulator, product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
Regulator-estimated resolution dates currently range from 10 Feb 2026 to 31 Mar 2027, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Mederti lists 6 clinically related alternatives for Topiramate (see the alternatives section above). Alternatives require clinical judgement — always confirm suitability with a pharmacist or prescriber and your national guidance before substituting.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Lacosamide · Topiramato · Clonazepam · Fenobarbital · Lamotrigine · Carbamazepina
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.